SPTX ▲ +1.5% - Seaport Therapeutics, Inc.
$SPTX Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
09-OCT-2026 07:00 AM ET
Share this post
More filings for $SPTX
SPTX ▲ +0.3% - Seaport Therapeutics, Inc.Oct 7, 2026SPTX - Seaport Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SPTX - Seaport Therapeutics, Inc. - SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 5, 2026SPTX SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 5, 2026
View full $SPTX filing history →💬 Comments
Loading comments…
Leave a comment